Zhongxin Lu

5.3k total citations · 2 hit papers
69 papers, 4.2k citations indexed

About

Zhongxin Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhongxin Lu has authored 69 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 26 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Zhongxin Lu's work include Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (12 papers). Zhongxin Lu is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (12 papers). Zhongxin Lu collaborates with scholars based in China, United States and Australia. Zhongxin Lu's co-authors include Feng Wu, Hui Wu, Y-Y Mo, Shengtao Zhu, Mo‐Fang Liu, Nancy H. Colburn, Carolyn M. Klinge, Shuiyi Liu, K. S. Ramos and Vilius Stribinskis and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhongxin Lu

67 papers receiving 4.1k citations

Hit Papers

miR-21-mediated tumor growth 2006 2026 2012 2019 2006 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. miR-21-mediated tumor growth
    2006 1.3k citations Zhongxin Lu et al. Oncogene profile →
  2. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
    2008 593 citations Zhongxin Lu, Mo‐Fang Liu et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongxin Lu China 29 3.1k 2.6k 581 353 226 69 4.2k
Junchao Cai China 33 2.4k 0.8× 1.4k 0.6× 532 0.9× 487 1.4× 199 0.9× 74 3.8k
Yingjian Liang China 29 1.6k 0.5× 999 0.4× 507 0.9× 349 1.0× 152 0.7× 94 3.0k
Linda A. Lee United States 21 1.8k 0.6× 1.1k 0.4× 513 0.9× 259 0.7× 135 0.6× 58 3.1k
Ping Ji United States 31 4.0k 1.3× 2.6k 1.0× 754 1.3× 321 0.9× 175 0.8× 95 5.1k
Bríd M. Ryan United States 27 2.3k 0.8× 1.4k 0.5× 1.1k 1.9× 381 1.1× 163 0.7× 80 3.7k
Sucheta Telang United States 27 1.8k 0.6× 1.5k 0.6× 613 1.1× 400 1.1× 115 0.5× 52 2.9k
Qinglei Gao China 33 2.1k 0.7× 756 0.3× 1.0k 1.8× 569 1.6× 240 1.1× 171 3.7k
Irfan A. Asangani United States 28 4.5k 1.5× 3.1k 1.2× 765 1.3× 378 1.1× 160 0.7× 50 5.8k
Matthias S. Matter Switzerland 32 1.6k 0.5× 1.0k 0.4× 903 1.6× 617 1.7× 365 1.6× 91 3.7k

Countries citing papers authored by Zhongxin Lu

Since Specialization
Citations

This map shows the geographic impact of Zhongxin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongxin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongxin Lu more than expected).

Fields of papers citing papers by Zhongxin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongxin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongxin Lu. The network helps show where Zhongxin Lu may publish in the future.

Co-authorship network of co-authors of Zhongxin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongxin Lu. A scholar is included among the top collaborators of Zhongxin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongxin Lu. Zhongxin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junning, Xiao Li, Jiaqi Zhang, et al.. (2025). Chromogen-embedded metal–organic frameworks nanozyme for smartphone-assisted visual detection of H2O2 and ampicillin. Chemical Engineering Journal. 506. 160066–160066. 1 indexed citations
2.
Zhao, Dan, et al.. (2024). Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review. Expert Review of Anticancer Therapy. 24(5). 239–251.
3.
Huang, Xu, et al.. (2024). 敲低结肠癌转移相关基因1促进RSL3诱导的结直肠癌细胞铁死亡. PubMed Central. 2 indexed citations
4.
Li, Kaiyu, Zhongxin Lu, Yuhan Tian, et al.. (2024). Deep learning models for MRI-based clinical decision support in cervical spine degenerative diseases. Frontiers in Neuroscience. 18. 1501972–1501972. 2 indexed citations
5.
Wu, Tangwei, et al.. (2023). Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis. International Journal of Medical Sciences. 21(2). 319–331. 1 indexed citations
6.
Huang, Lifeng, Hongmei Zhang, Dan Zhao, Hui Hu, & Zhongxin Lu. (2021). Interleukin-38 Suppresses Cell Migration and Proliferation and Promotes Apoptosis of Colorectal Cancer Cell Through Negatively Regulating Extracellular Signal-Regulated Kinases Signaling. Journal of Interferon & Cytokine Research. 41(10). 375–384. 16 indexed citations
7.
Liu, Shuiyi, Weiqun Chen, Hui Hu, et al.. (2021). Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Research. 23(1). 115–115. 24 indexed citations
8.
Yu, Xinfang, Wei Li, Qipan Deng, et al.. (2020). MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis. Blood. 137(12). 1615–1627. 26 indexed citations
9.
Wang, Hui, Hui Hu, Zhenzhao Luo, et al.. (2020). miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer. Bioscience Reports. 40(9). 14 indexed citations
10.
Zhang, Hongmei, et al.. (2020). Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiology and Infection. 148. e139–e139. 104 indexed citations
11.
Li, You, Hui Hu, Yan Ge, et al.. (2020). Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules. Bioscience Reports. 40(2). 6 indexed citations
12.
Wang, Changzheng, Hongmei Zhang, Rongrong Deng, et al.. (2020). Red cell distribution width (RDW): a prognostic indicator of severe COVID-19. Annals of Translational Medicine. 8(19). 1230–1230. 55 indexed citations
13.
Zhu, Man, Zheqiong Tan, Zhenzhao Luo, et al.. (2019). Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis. Bioscience Reports. 39(9). 11 indexed citations
14.
Deng, Qipan, Hui Hu, Xinfang Yu, et al.. (2019). Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nature Communications. 10(1). 5061–5061. 19 indexed citations
15.
Lu, Zhongxin, et al.. (2016). Evaluation of Anti-tumor and Chemoresistance-lowering Effects of Pectolinarigenin from <i>Cirsium japonicum</i> Fisch ex DC in Breast Cancer. Tropical Journal of Pharmaceutical Research. 15(3). 547–547. 4 indexed citations
16.
Kong, Qing, Haojie Lu, Zhongxin Lu, et al.. (2014). Pectolinarigenin - A Flavonoid Compound from <i>Cirsium Japonicum</i> with Potential Anti-proliferation Activity in MCF- 7 Breast Cancer Cell. Tropical Journal of Pharmaceutical Research. 13(2). 225–225. 21 indexed citations
17.
Becker, L E, Zhongxin Lu, Weiqun Chen, et al.. (2012). A Systematic Screen Reveals MicroRNA Clusters That Significantly Regulate Four Major Signaling Pathways. PLoS ONE. 7(11). e48474–e48474. 23 indexed citations
18.
Yang, Lifang, Zhongxin Lu, Xiaoqian Ma, Ya Cao, & Lunquan Sun. (2010). A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene. Molecules. 15(9). 6127–6139. 34 indexed citations
19.
Wang, Zhenlian, Feijun Luo, Lili Li, et al.. (2010). STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. European Journal of Cancer. 46(16). 2996–3006. 72 indexed citations
20.
Lu, Zhongxin, Mo‐Fang Liu, Vilius Stribinskis, et al.. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 27(31). 4373–4379. 593 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junchao Cai Breakdown of academic impact, for papers by Yingjian Liang Breakdown of academic impact, for papers by Linda A. Lee Breakdown of academic impact, for papers by Ping Ji Breakdown of academic impact, for papers by Bríd M. Ryan Breakdown of academic impact, for papers by Sucheta Telang Breakdown of academic impact, for papers by Qinglei Gao Breakdown of academic impact, for papers by Irfan A. Asangani Breakdown of academic impact, for papers by Matthias S. Matter
Rankless by CCL
2026